Axsome Therapeutics's market cap is currently $6.30B. The company's EPS TTM is $-5.995; its P/E ratio is ―; Axsome Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-1.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 270.60M	$ 50.04M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 244.53M	$ 44.84M	$ -1.16M	$ -77.72K	$ -37.33K
Operating Income	$ -231.82M	$ -176.50M	$ -124.71M	$ -99.14M	$ -67.25M
EBITDA	$ -224.99M	$ -174.23M	$ -123.55M	$ -99.06M	$ -67.21M
Net Income	$ -239.24M	$ -197.77M	$ -134.94M	$ -105.39M	$ -69.69M
Balance Sheet
Cash & Short-Term Investments	$ 386.19M	$ 200.84M	$ 86.47M	$ 183.88M	$ 219.97M
Total Assets	$ 588.24M	$ 331.48M	$ -338.36M	$ 186.13M	$ 220.55M
Total Debt	$ 186.37M	$ 94.68M	$ 49.71M	$ 50.12M	$ 19.93M
Net Debt	$ -199.82M	$ -106.16M	$ -36.76M	$ -133.75M	$ -200.03M
Total Liabilities	$ 397.26M	$ 221.92M	$ 70.84M	$ 72.34M	$ 41.83M
Stockholders' Equity	$ 190.98M	$ 109.56M	$ -409.20M	$ -278.80M	$ -175.90M
Cash Flow
Free Cash Flow	$ -145.66M	$ -117.21M	$ -108.53M	$ -78.50M	$ -46.39M
Operating Cash Flow	$ -145.08M	$ -116.51M	$ -108.23M	$ -78.46M	$ -46.38M
Investing Cash Flow	$ -582.00K	$ -53.70M	$ -307.55K	$ -45.89K	$ -16.12K
Financing Cash Flow	$ 331.01M	$ 284.58M	$ 11.13M	$ 42.41M	$ 252.39M

Currency in USD

Axsome Therapeutics Earnings and Revenue History

Income Statement >

Axsome Therapeutics Debt to Assets

Balance Sheet >

Axsome Therapeutics Cash Flow

Cash Flow >

Axsome Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing